Member Directory

NuvOx Therapeutics

Website: http://www.nuvoxpharma.com/

Member Contact: Bryan Unger

Position: Director of Business Development

Industry: Biotech & Pharmaceuticals

Company Profile:

NuvOx Therapeutics is a clinical-stage biopharma developing a novel therapeutic, NanO2, to treat hypoxia. We have three ongoing clinical programs in Glioblastoma, Stroke, and ARDS. Our Phase I trial in Glioblastoma was conducted in Australia and was a success. We are interested in exploring future trial and development opportunities in Australia.

Home

News & opinion

Events

CLICK HERE TO SUBSCRIBE TO OUR NEWSLETTER

BioMelbourne Network respectfully acknowledges the Traditional Custodians of the unceded lands and waters of Victoria: the Bunurong, Gunaikurnai and Wurundjeri peoples, on which the BioMelbourne Network and our Victorian members work, and as well as the lands and waters of our members further afield. We pay respect to their Elders past and present. As Australia’s first scientists, we acknowledge the significant contribution that they and other Aboriginal and Torres Strait Islander people have made and continue to make to the research and knowledge systems that inform our community and our sector.

We acknowledge that Aboriginal and Torres Strait Islander people continue to live in a spiritual and sacred relationship with this country and recognise our responsibility to continue to work towards reconciliation.